CYB003

deuterated psilocin analog · Cybin IRL Limited

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CYB003, covering 2024-03-25 to 2026-08-12. Get the full timeline:

Most recent: Clinical Trial Update: "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" [Phase 3]